| DataElement |
| publicId |
14913015 |
| version |
1 |
| longName |
Therapeutic Procedure Pharmacologic Substance or Chemical NCI Thesaurus Name |
| shortName |
14913014v1.00:14912947v1.00 |
| definition |
The name of the therapeutic agent(s) as captured in the Pharmacological Substance (C1909) or Drug or Chemical by Structure (C1913) branch of the National Cancer Institute Thesaurus (NCIt) hierarchy tree. |
| context |
CRDC |
| origin |
CRDC:Cancer Research Data Commons |
| workflowStatus |
RELEASED |
| registrationStatus |
Standard |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
7/16/26 reviewed/added missing CIDC Appendix A Alts, definition, and CSI. jk
7/6/2026 Added CCDI alt name, def, CSI. Per email from P.Dunn, CCDI no longer using 13579886, which will be retired once PCDC and Ped Cancer approve the change. mr;
6/16/26 Corrected definition for consistency with CRDC def. mr;
7/176/25 upd chg note. jk;
5/22/25 Classified in GDC Candidate CSI, added alt name, alt def, per June 2025 GDC DD. sl;
6/24/24 Add CRDC Alt name/Def, CSI. Released and upd RS to Standard. jk
4/29/24 created by ref CDE for CRDC Std request; Ped gps use CDE 13579886 Therapeutic Procedure Agent Name. jk |
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2026-07-16 |
| DataElementConcept |
| publicId |
14913014 |
| version |
1 |
| longName |
Therapeutic Procedure Pharmacologic Substance or Chemical |
| shortName |
2512834v1.00:14913013v1.00 |
| definition |
An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Substances that are grouped or classified by chemical composition. |
| context |
CRDC |
| origin |
CRDC:Cancer Research Data Commons |
| workflowStatus |
RELEASED |
| registrationStatus |
Qualified |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
6/24/24 Released and upd RS to Qualified. jk |
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-06-24 |
| ObjectClass |
| publicId |
2512834 |
| version |
1 |
| longName |
Therapeutic Procedure |
| shortName |
C49236 |
| definition |
An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process. |
| context |
NCIP |
| origin |
NCI Thesaurus |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2006-08-21 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
UMLLOADER_AGNIS |
| dateCreated |
2006-08-21 |
| modifiedBy |
SBREXT |
| dateModified |
2007-11-07 |
| Concepts |
| longName |
Therapeutic Procedure |
| conceptCode |
C49236 |
| definition |
Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
|
| Property |
| publicId |
14913013 |
| version |
1 |
| longName |
Pharmacologic Substance Drug or Chemical by Structure |
| shortName |
C1909:C1913 |
| definition |
Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Substances that are grouped or classified by chemical composition. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| Concepts |
| longName |
Pharmacologic Substance |
| conceptCode |
C1909 |
| definition |
Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
1 |
|
| longName |
Drug or Chemical by Structure |
| conceptCode |
C1913 |
| definition |
Substances that are grouped or classified by chemical composition. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
|
| ConceptualDomain |
| publicId |
2435018 |
| version |
1 |
| longName |
Clinical or Research Activity |
| shortName |
C16203 |
| definition |
Any specific activity undertaken during the course of a clinical study or research protocol. |
| context |
NCIP |
| origin |
NCI Thesaurus |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2005-12-06 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
CURTIST |
| dateCreated |
2005-12-06 |
| modifiedBy |
SBR |
| dateModified |
2006-12-20 |
|
|
| ValueDomain |
| publicId |
14912947 |
| version |
1 |
| longName |
NCI Thesaurus Pharmacologic Substance or Chemical Name |
| shortName |
14912947v1.00 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Substances that are grouped or classified by chemical composition._The words or language units by which a thing is known. |
| context |
CRDC |
| type |
Enumerated by Reference |
| referenceTerminology |
NCI Thesaurus|C43816 |
| referenceTerminologyDataValueSource |
Term |
| dataType |
CHARACTER |
| minLength |
|
| maxLength |
200 |
| minValue |
|
| maxValue |
|
| decimalPlace |
|
| origin |
CRDC:Cancer Research Data Commons |
| workflowStatus |
RELEASED |
| registrationStatus |
Qualified |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
7/15/24 Upd PV to point to concept in hierarchy, not just to the concept. mr;
6/24/24 upd VD max length to 200, released and upd RS to Qualified; resolved by-ref PV tool semantics. jk; 5/17/24 Upd PVs to be the link to C2991 and C1909. mr |
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
COLBERTM |
| dateModified |
2024-07-15 |
| PermissibleValues |
| publicId |
9160953 |
| value |
https://evsexplore.semantics.cancer.gov/evsexplore/hierarchy/ncit/C1913 |
| valueDescription |
|
| origin |
|
| beginDate |
2024-04-29 |
| endDate |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
COLBERTM |
| dateModified |
2024-07-15 |
| ValueMeaning |
| publicId |
14905526 |
| version |
1 |
| longName |
NCI Thesaurus Drug or Chemical by Structure |
| shortName |
14905526v1.00 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations._Substances that are grouped or classified by chemical composition. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-23 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-23 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| Concepts |
| longName |
Drug or Chemical by Structure |
| conceptCode |
C1913 |
| definition |
Substances that are grouped or classified by chemical composition. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
| longName |
NCI Thesaurus |
| conceptCode |
C43816 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
1 |
|
|
|
|
| publicId |
9160955 |
| value |
Not Otherwise Specified |
| valueDescription |
|
| origin |
|
| beginDate |
2024-04-29 |
| endDate |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| ValueMeaning |
| publicId |
2853071 |
| version |
1 |
| longName |
Not Otherwise Specified |
| shortName |
2853071 |
| definition |
Not characterized in any other way. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2009-03-19 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
CURTIST |
| dateCreated |
2009-03-19 |
| modifiedBy |
SBR |
| dateModified |
2018-01-19 |
| Concepts |
| longName |
Not Otherwise Specified |
| conceptCode |
C19594 |
| definition |
Not characterized in any other way. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
| Designations |
| languageName |
ENGLISH |
| name |
Stomatococcus nos |
| type |
VM Alt Name |
| context |
COG |
| id |
0141062B-20E7-3834-E050-BB89AD4362EC |
| createdBy |
Wendy Wong |
| dateCreated |
2014-08-22 |
| modifiedBy |
ONEDATA |
| dateModified |
2014-08-22 |
|
|
|
|
| publicId |
9160956 |
| value |
Unknown |
| valueDescription |
|
| origin |
|
| beginDate |
2024-04-29 |
| endDate |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| ValueMeaning |
| publicId |
5682953 |
| version |
1 |
| longName |
Unknown |
| shortName |
5682953 |
| definition |
Not known, not observed, not recorded, or refused. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2017-02-27 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
3/4/25 Added alt VM names per RFC 26 CR 1. sl |
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
ALEYR |
| dateCreated |
2017-02-27 |
| modifiedBy |
COLBERTM |
| dateModified |
2025-04-17 |
| Concepts |
| longName |
Unknown |
| conceptCode |
C17998 |
| definition |
Not known, observed, recorded; or reported as unknown by the data contributor. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
| Designations |
| languageName |
ENGLISH |
| name |
UNKNOWN |
| type |
OMOP Name |
| context |
CDMH |
| id |
66585890-8D69-137D-E053-F662850AA2F9 |
| createdBy |
Denise Warzel |
| dateCreated |
2018-03-01 |
| modifiedBy |
DWARZEL |
| dateModified |
2018-09-19 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
FHIR Name |
| context |
NCIP |
| id |
66585890-8D6A-137D-E053-F662850AA2F9 |
| createdBy |
Denise Warzel |
| dateCreated |
2018-03-01 |
| modifiedBy |
ONEDATA |
| dateModified |
2018-03-01 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
Sentinel Name |
| context |
CDMH |
| id |
66585890-8D6B-137D-E053-F662850AA2F9 |
| createdBy |
Denise Warzel |
| dateCreated |
2018-03-01 |
| modifiedBy |
DWARZEL |
| dateModified |
2018-09-19 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
PCORNet Name |
| context |
CDMH |
| id |
714A2A3D-EB9D-737F-E053-F662850A62AC |
| createdBy |
Gwen Hartley Deen |
| dateCreated |
2018-07-18 |
| modifiedBy |
DWARZEL |
| dateModified |
2018-09-19 |
|
| languageName |
ENGLISH |
| name |
unknown |
| type |
Sentinel Name |
| context |
CDMH |
| id |
7746074F-35B1-3158-E053-F662850A6C57 |
| createdBy |
Denise Warzel |
| dateCreated |
2018-10-02 |
| modifiedBy |
ONEDATA |
| dateModified |
2018-10-02 |
|
| languageName |
ENGLISH |
| name |
Unk |
| type |
VM Alt Name |
| context |
NCIP |
| id |
E10A6ABC-4D1B-2FAE-E053-731AD00A4F5C |
| createdBy |
Angela Kummerow |
| dateCreated |
2022-06-14 |
| modifiedBy |
KUMMEROA |
| dateModified |
2022-06-14 |
|
| languageName |
ENGLISH |
| name |
Unknown Tumor Status |
| type |
CRDC Alt Name |
| context |
CRDC |
| id |
039710A3-23A4-1353-E063-731AD00A8B59 |
| createdBy |
Maureen Ryan |
| dateCreated |
2023-08-23 |
| modifiedBy |
COLBERTM |
| dateModified |
2023-08-23 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
VM Alt Name |
| context |
CDMH |
| id |
0C020FD5-E54D-4ADF-E063-731AD00A021C |
| createdBy |
Gwen Deen |
| dateCreated |
2023-12-08 |
| modifiedBy |
GDEEN |
| dateModified |
2023-12-08 |
|
| languageName |
ENGLISH |
| name |
UN=Unknown |
| type |
VM Alt Name |
| context |
CDMH |
| id |
0C026688-71EB-5921-E063-731AD00AA679 |
| createdBy |
Gwen Deen |
| dateCreated |
2023-12-08 |
| modifiedBy |
GDEEN |
| dateModified |
2023-12-08 |
|
| languageName |
ENGLISH |
| name |
UN=Unknown |
| type |
PCORNet Name |
| context |
CDMH |
| id |
0CD3D410-1D82-6883-E063-731AD00AC500 |
| createdBy |
Gwen Deen |
| dateCreated |
2023-12-18 |
| modifiedBy |
GDEEN |
| dateModified |
2023-12-18 |
|
| languageName |
ENGLISH |
| name |
Unknown/not reported |
| type |
VM Alt Name |
| context |
COG |
| id |
0E383BFB-3CBF-25E8-E063-731AD00A63EB |
| createdBy |
Mounika Maddineni |
| dateCreated |
2024-01-05 |
| modifiedBy |
MMADDINENI |
| dateModified |
2024-01-05 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
OMOP Name |
| context |
CDMH |
| id |
164D7AC7-7F1D-6D0F-E063-731AD00A282A |
| createdBy |
Xiaoyun Zhang |
| dateCreated |
2024-04-17 |
| modifiedBy |
ZHWENDY |
| dateModified |
2024-04-17 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
CDA Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC43-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
unknown |
| type |
CDA Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC44-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
GC Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC45-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
GDC Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC46-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
ICDC Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC47-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Unknown |
| type |
PDC Alt Name |
| context |
CRDC |
| id |
2F8F2CAB-CC48-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
unknown |
| type |
HTAN Alt Name |
| context |
HTAN |
| id |
2F8F2CAB-CC49-37FC-E063-731AD00AA04C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
unknown |
| type |
PDC Alt Name |
| context |
CRDC |
| id |
32FF09E4-4A0F-650D-E063-731AD00A5B99 |
| createdBy |
Maureen Ryan |
| dateCreated |
2025-04-17 |
| modifiedBy |
COLBERTM |
| dateModified |
2025-04-17 |
|
|
|
|
| publicId |
9160957 |
| value |
Not Reported |
| valueDescription |
|
| origin |
|
| beginDate |
2024-04-29 |
| endDate |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| ValueMeaning |
| publicId |
5612322 |
| version |
1 |
| longName |
Not Reported |
| shortName |
5612322v1.00 |
| definition |
Not provided or available. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2017-01-03 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
3/4/25 Added alt VM names per RFC 26 CR 1. sl;
10/10/23 changed Long Name from "Not Stated" to match NCIt Preferred name and current caDSR concept Long Name of "Not Reported" per Brenda.Janice . LS |
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
ALEYR |
| dateCreated |
2017-01-03 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
| Concepts |
| longName |
Not Reported |
| conceptCode |
C43234 |
| definition |
Not provided or available. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
| Designations |
| languageName |
ENGLISH |
| name |
Not reported |
| type |
VM Alt Name |
| context |
COG |
| id |
EDAF8130-FB17-4970-E053-731AD00A3E2F |
| createdBy |
Angela Kummerow |
| dateCreated |
2022-11-17 |
| modifiedBy |
KUMMEROA |
| dateModified |
2022-11-17 |
|
| languageName |
ENGLISH |
| name |
Not reported |
| type |
PCDC Alt Name |
| context |
Pediatric Cancer |
| id |
F70C841B-1BAB-3136-E053-731AD00AEC0A |
| createdBy |
Maureen Ryan |
| dateCreated |
2023-03-16 |
| modifiedBy |
COLBERTM |
| dateModified |
2023-03-16 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
VM Alt Name |
| context |
COG |
| id |
F7E64D3D-671D-5F5B-E053-731AD00A7EA8 |
| createdBy |
Angela Kummerow |
| dateCreated |
2023-03-27 |
| modifiedBy |
KUMMEROA |
| dateModified |
2023-03-27 |
|
| languageName |
ENGLISH |
| name |
Not reported |
| type |
Manually-curated |
| context |
NCIP |
| id |
01E36070-B407-2894-E063-731AD00A26B9 |
| createdBy |
Gwen Deen |
| dateCreated |
2023-08-01 |
| modifiedBy |
GDEEN |
| dateModified |
2023-08-01 |
|
| languageName |
ENGLISH |
| name |
Not Stated |
| type |
VM Alt Name |
| context |
NCIP |
| id |
075F5912-5BB3-3B40-E063-731AD00A37FA |
| createdBy |
Lamia Sokker |
| dateCreated |
2023-10-10 |
| modifiedBy |
SOKKERL |
| dateModified |
2023-10-10 |
|
| languageName |
ENGLISH |
| name |
Not stated in Report |
| type |
VM Alt Name |
| context |
CCTG |
| id |
097FC64F-5B06-6592-E063-731AD00AC610 |
| createdBy |
Cassandra Lohnes |
| dateCreated |
2023-11-06 |
| modifiedBy |
CLOHNES |
| dateModified |
2023-11-06 |
|
| languageName |
ENGLISH |
| name |
Not Stated in Report |
| type |
OID, CCTG |
| context |
CCTG |
| id |
09A6371C-80E0-502C-E063-731AD00A26F5 |
| createdBy |
Cassandra Lohnes |
| dateCreated |
2023-11-08 |
| modifiedBy |
CLOHNES |
| dateModified |
2023-11-08 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
CRDC Alt Name |
| context |
CRDC |
| id |
0F53F53A-F7B0-4F25-E063-731AD00A3B14 |
| createdBy |
Bobbie Fincham |
| dateCreated |
2024-01-19 |
| modifiedBy |
FINCHAMB |
| dateModified |
2024-01-19 |
|
| languageName |
ENGLISH |
| name |
-1 |
| type |
TCIA Alt Name |
| context |
CIP |
| id |
1F44C19A-94C2-5731-E063-731AD00AF175 |
| createdBy |
Bobbie Fincham |
| dateCreated |
2024-08-09 |
| modifiedBy |
FINCHAMB |
| dateModified |
2024-08-09 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
CDA Alt Name |
| context |
CRDC |
| id |
2F8F12E0-3D58-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
not reported |
| type |
CDA Alt Name |
| context |
CRDC |
| id |
2F8F12E0-3D59-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
GC Alt Name |
| context |
CRDC |
| id |
2F8F12E0-3D5A-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
GDC Alt Name |
| context |
CRDC |
| id |
2F8F12E0-3D5B-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
PDC Alt Name |
| context |
CRDC |
| id |
2F8F12E0-3D5C-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
| languageName |
ENGLISH |
| name |
Not Reported |
| type |
HTAN Alt Name |
| context |
HTAN |
| id |
2F8F12E0-3D5D-33DC-E063-731AD00A3A1C |
| createdBy |
Sarah Lauer |
| dateCreated |
2025-03-04 |
| modifiedBy |
SLAUER |
| dateModified |
2025-03-04 |
|
|
|
|
| publicId |
9160959 |
| value |
https://evsexplore.semantics.cancer.gov/evsexplore/hierarchy/ncit/C1909 |
| valueDescription |
|
| origin |
|
| beginDate |
2024-04-29 |
| endDate |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
COLBERTM |
| dateModified |
2024-05-17 |
| ValueMeaning |
| publicId |
14912951 |
| version |
1 |
| longName |
NCI Thesaurus Pharmacologic Substance |
| shortName |
14912951v1.00 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| Concepts |
| longName |
Pharmacologic Substance |
| conceptCode |
C1909 |
| definition |
Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
| longName |
NCI Thesaurus |
| conceptCode |
C43816 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
1 |
|
|
|
|
|
| ConceptualDomain |
| publicId |
2435022 |
| version |
1 |
| longName |
Disease, Disorder or Finding |
| shortName |
C7057 |
| definition |
Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included. |
| context |
NCIP |
| origin |
NCI Thesaurus |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2005-12-06 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
CURTIST |
| dateCreated |
2005-12-06 |
| modifiedBy |
SBR |
| dateModified |
2006-12-20 |
|
| RepresentationTerm |
| publicId |
14912946 |
| version |
1 |
| longName |
NCI Thesaurus Pharmacologic Substance Drug or Chemical by Structure Name |
| shortName |
14912946v1.00 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Substances that are grouped or classified by chemical composition._The words or language units by which a thing is known. |
| context |
NCIP |
| origin |
|
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| latestVersionIndicator |
Yes |
| beginDate |
2024-04-29 |
| endDate |
|
| changeDescription |
|
| administrativeNotes |
|
| unresolvedIssues |
|
| deletedIndicator |
No |
| createdBy |
JKNABLE |
| dateCreated |
2024-04-29 |
| modifiedBy |
JKNABLE |
| dateModified |
2024-04-29 |
| Concepts |
| longName |
NCI Thesaurus |
| conceptCode |
C43816 |
| definition |
The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
3 |
|
| longName |
Pharmacologic Substance |
| conceptCode |
C1909 |
| definition |
Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
2 |
|
| longName |
Drug or Chemical by Structure |
| conceptCode |
C1913 |
| definition |
Substances that are grouped or classified by chemical composition. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
No |
| displayOrder |
1 |
|
| longName |
Name |
| conceptCode |
C42614 |
| definition |
The words or language units by which a thing is known. |
| evsSource |
NCI_CONCEPT_CODE |
| primaryIndicator |
Yes |
| displayOrder |
0 |
|
|
|
|
| ClassificationSchemes |
| publicId |
8064110 |
| version |
1 |
| longName |
GC (General Commons) |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
14470388 |
| version |
1 |
| longName |
Imaging |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
|
|
| publicId |
10429357 |
| version |
1 |
| longName |
GDC (Genomic Data Commons) |
| context |
CRDC |
| workflowStatus |
DRAFT NEW |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
14506028 |
| version |
1 |
| longName |
Candidate New GDC CDEs |
| context |
CRDC |
| workflowStatus |
DRAFT NEW |
| registrationStatus |
Application |
|
|
|
| publicId |
10466051 |
| version |
1 |
| longName |
All CRDC Standard CDEs |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
10466198 |
| version |
1 |
| longName |
Treatment |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
|
|
| publicId |
11518160 |
| version |
1 |
| longName |
CTDC (Clinical and Translational Data Commons) |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
14413707 |
| version |
1 |
| longName |
CTDC Model |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
| publicId |
14931970 |
| version |
1 |
| longName |
Clinical Trial |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
| publicId |
16075375 |
| version |
1 |
| longName |
CIDC Model |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
| publicId |
16075991 |
| version |
1 |
| longName |
Treatment Dose |
| context |
CRDC |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
|
|
| publicId |
13574489 |
| version |
1 |
| longName |
CCDI (Childhood Cancer Data Initiative) |
| context |
Pediatric Cancer |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
13594092 |
| version |
1 |
| longName |
Participant |
| context |
Pediatric Cancer |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
| publicId |
13596242 |
| version |
1 |
| longName |
Therapeutic Procedure |
| context |
Pediatric Cancer |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
|
|
| publicId |
15711259 |
| version |
1 |
| longName |
RCI (Rare Cancer Initiative) |
| context |
Pediatric Cancer |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
| ClassificationSchemeItems |
| publicId |
15713367 |
| version |
1 |
| longName |
Treatment |
| context |
Pediatric Cancer |
| workflowStatus |
RELEASED |
| registrationStatus |
Application |
|
|
|
|
| AlternateNames |
| name |
therapeutic_agents |
| type |
GC Alt Name |
| context |
CRDC |
|
| name |
targeted_therapy |
| type |
CTDC Alt Name |
| context |
CRDC |
|
| name |
non_targeted_therapy |
| type |
CTDC Alt Name |
| context |
CRDC |
|
| name |
Therapeutic Agent |
| type |
CRDC Alt Name |
| context |
CRDC |
|
| name |
non_targeted_therapy |
| type |
CTDC Table |
| context |
CRDC |
|
| name |
targeted_therapy |
| type |
CTDC Table |
| context |
CRDC |
|
| name |
therapeutic_agents |
| type |
GDC Alt Name |
| context |
GDC |
|
| name |
treatment_agent |
| type |
CCDI Alt Name |
| context |
Pediatric Cancer |
|
| name |
treatment |
| type |
CCDI Table |
| context |
Pediatric Cancer |
|
| name |
therapy_agent_name |
| type |
CIDC Alt Name |
| context |
CRDC |
|
| name |
therapy_agent_dose |
| type |
CIDC Table |
| context |
CRDC |
|
|
| ReferenceDocuments |
| documentName |
PQT |
| documentText |
Therapeutic Agent |
| documentType |
Preferred Question Text |
| url |
|
| context |
CRDC |
|
| documentName |
CIDC Example |
| documentText |
Tremelimumab, Olaparib, ivolumab, Paclitaxel, Carboplatin, Atezolizumab, Ipilimumab, Valacyclovir, Aglatimagene Besadenovec, Fluorouracil, Potassium |
| documentType |
EXAMPLE |
| url |
|
| context |
CRDC |
|
|
|